Cyclic RGD-containing peptides: in silico exploration against BCL-X(L)

Сyclic peptides attract attention for possible applications in cancer treatment. We examined the abili­ty of six cyclic RGD-containing peptides-based compounds to inhibit B-cell lymphoma-extra-large (Bcl-XL) (PDB ID: 3zk6) using the in silico method. We observed that the addition of electron withdra...

Full description

Bibliographic Details
Published in:The Ukrainian Biochemical Journal
Main Authors: A. K. Oyebamiji, E. T. Akintayo, C. O. Akintayo, H. O. Aworinde, O. D. Adekunle, S. A. Akintelu
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2023-04-01
Subjects:
bcl-x(l)
carcinogesis
cyclic rgd peptides
in silico study
modeling­
peptide-protein interaction
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2023/06/Oyebamiji_95_2.pdf

Internet

http://ukrbiochemjournal.org/wp-content/uploads/2023/06/Oyebamiji_95_2.pdf

Similar Items